The public paid for “Moderna's” vaccine, and now we're going to pay again(pluralistic.net)

13 pointsby cstever3 tahun yang lalu5 comments

The public paid for “Moderna's” vaccine, and now we're going to pay again

https://pluralistic.net/2023/01/25/nationalize-moderna/#herd-immunity

5 comments

Arnt3 tahun yang lalu

The money that paid for my flat came from a startup, that startup was set up in one of those small European countries where the state taxes people heavily and pays for many things.

In the years when I earned less than the average taxi driver, we we wrote our code and didn't worry about health insurance. We received no subsidies, but the the state^Wpublic paid a lot, and then later the public paid for the products we developed. Unfair?

Those same small European countries have a lot of successful businesses. One might suspect that paying for innovation brings profit — on average. I personally think it does.

It's great that Moderna exists IMO, even if its existence involves paying both before and after the product reached saleability.

feet3 tahun yang lalu

Having state sponsored health insurance is definitely not the same thing as taxes paying for a vaccine then the private company deciding to charge people again

hulitu3 tahun yang lalu

Moderna is a private enterprise.

paulryanrogers3 tahun yang lalu

Whose research was largely funded by public taxes

Arnt3 tahun yang lalu

Not so different from me… the startup that paid for the floor on which I stand emerged from a place whose name may be translated as "medical/technical research something", located between a hospital and a university. While that startup received no subsidies directly, I don't mind admitting that the subsidies that went into that area (from several parts of the state) were key to starting up.

Moderna struck it rich. Most of the companies that are founded on the fringes of hospitals and universities don't, they may lead to someone owning a nice flat, if even that.

If you want to block the occasional startup from striking it rich, you either have to improve the deal in another way or accept that the innovation decreases. For example, if you were to pay all of the research instead of most, you might be able to get all of the proceeds from the successes and keep the innovation going. As I understand it, that's a big "if" because the countries that have tried it haven't been very good at picking the right research to fund.